CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
3.80 / 10
Netural
Analyst sentiment is overwhelmingly bullish (100% Strong Buy) from one source, yet historical win-rate is 0%, raising doubts. Fund-flow data indicate overall positive movement (score 7.6/10), with block and extra-large inflows positive, but small/medium/large flows mixed, suggesting institutional interest tempered by retail volatility.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-23
InstitutionMaxim Group
Times predicted2
Historical Win Rate0.0%
Is money flowing into or out of CTOR?
- CTOR holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.80/10 (Netural).
